Doyle Thomas James's Form 4 filing
Kura Oncology, Inc. (KURA) · filed Jan 28, 2025
- Accession no.
- 0000950170-25-010137
- Filed
- Jan 28, 2025
- Trade date
- Jan 28, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $38.9K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Doyle Thomas JamesCIK 0001910331 | Officer (SVP, Finance & Accounting) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2025 | Common Stock | SSaleDisposed | −2,241 | $7.87 | −$17,636.67 | 90,901 | Direct | |
| Jan 28, 2025 | Common Stock | SSaleDisposed | −887 | $7.87 | −$6,980.69 | 90,014 | Direct | |
| Jan 28, 2025 | Common Stock | SSaleDisposed | −699 | $7.87 | −$5,501.13 | 89,315 | Direct | |
| Jan 28, 2025 | Common Stock | SSaleDisposed | −1,122 | $7.87 | −$8,830.14 | 88,193 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.